Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » New Leadership in Mesulam Center for Cognitive Neurology and Alzheimer’s Disease
Campus News

New Leadership in Mesulam Center for Cognitive Neurology and Alzheimer’s Disease

By Northwestern University Feinberg School of MedicineOct 31, 2022
Share
Facebook Twitter Email

Mesulam announces he is stepping down; Vassar named director

M. Marsel Mesulam, MD, the Ruth Dunbar Davee Professor of Neuroscience, has announced that he will be stepping down as director of the Mesulam Center for Cognitive Neurology and Alzheimer’s Disease.

After 28 years of outstanding leadership, M. Marsel Mesulam, MD, the Ruth Dunbar Davee Professor of Neuroscience in the Ken and Ruth Davee Department of Neurology, an international authority on primary progressive aphasia (PPA), has announced that he will be stepping down as director of the Mesulam Center for Cognitive Neurology and Alzheimer’s Disease, effective January 1st. He will remain on the faculty to continue his research. 

Mesulam will be succeeded by Robert Vassar, PhD, the Davee Professor of Alzheimer Research and professor of Neurology and of Cell and Developmental Biology, and scientific director of Behavioral Neurology in the Department of Neurology. He is also the Director of the NIH-funded Northwestern Alzheimer’s Disease Research Center.

Mesulam to transfer leadership of the Mesulam Center

Mesulam has made important contributions to the understanding of neural structure, defining neurotransmitter pathways and how deterioration in these pathways contributes to dementia. Discoveries Mesulam made about primary progressive aphasia in the 1980s have brought clarity to some of the mysteries of dementia and have also provided a tool for scientists to understand how language is mapped in the human brain.  

“Marsel has built a nexus of Alzheimer’s research at Feinberg, generating exceptional clinical and scientific research, building a stellar national reputation, and providing much-needed hope for the millions affected by this disease,” said Eric G. Neilson, MD, vice president for Medical Affairs and Lewis Landsberg Dean at Feinberg. “We are grateful for his many years of dedication, and we know Bob will continue to advance Feinberg’s intellectual eminence in the field of Alzheimer’s research.” 

Mesulam’s contributions to Alzheimer’s research have been widely celebrated. In 2010, he received the Bengt Winblad Lifetime Achievement from the Alzheimer’s Association, and in 2014, the Potamkin Prize from the American Academy of Neurology. He has authored or co-authored more than 200 peer-reviewed papers during his career. 

Vassar Named Next Director of the Mesulam Center  

Robert Vassar, PhD, the Davee Professor of Alzheimer Research and professor of Neurology and of Cell and Developmental Biology will be the next director of the Mesulam Center for Cognitive Neurology and Alzheimer’s Disease.

Vassar, a renowned expert in Alzheimer’s disease, joined Feinberg in 2001. He earned his doctorate from the University of Chicago in 1992 and completed a postdoctoral fellowship in molecular neuroscience at Columbia University in 1996. As his mother was diagnosed with Alzheimer’s disease, he has devoted his career to finding a treatment.  He is deeply committed to advancing the clinical and basic science in the field of progressive dementias.

“I am honored to become the next Director of the Mesulam Center and to begin our work on achieving the next clinical and basic science summits, wherever the science takes us,” Vassar said. “The Center has many talented investigators and I look forward to working with each of these wonderful people.” 

Vassar studies the molecular and cellular mechanisms of Alzheimer’s disease, with the goal of contributing to effective disease-modifying therapies. In 1999 he identified BACE1, an enzyme that makes beta-amyloid, a protein that builds up in the brains of Alzheimer’s patients and leads to the death of brain cells. He continued his work on BACE1 at Feinberg, laying the groundwork for BACE1 inhibition as a new therapeutic strategy; as a result, BACE1-inhibitor drugs have been tested in clinical trials. He is also studying the links between inflammation, protein deposits, and risk factor genes that contribute to Alzheimer’s disease.

Vassar has received many prestigious honors, including the MetLife Foundation Award for Medical Research in Alzheimer’s Disease in 2007, the Potamkin Prize from the American Academy of Neurology in 2009 and the Zenith Fellows Award from the Alzheimer’s Association in 2014. He is also a Fellow of the American Association for the Advancement of Science, a member of the Dana Alliance for Brain Initiatives, and his work has contributed to the award of the Nobel Prize in Physiology or Medicine to Richard Axel in 2004. He has authored or co-authored more than 130 papers in peer-reviewed journals, including Science, Nature, Cell, Science Translational Medicine, Nature Neuroscience, Neuron, PNAS, Lancet Neurology, JAMA Neurology and Journal of Experimental Medicine.

Faculty Leadership Neurology Neurology and Neuroscience Research
Share. Facebook Twitter Email

Related Posts

Mar 29, 2023

Adolescent Sexual Health Program Receives Funding for Social Marketing Campaign

Mar 29, 2023

The Future of IgE-Mediated Allergy Research and Treatments

Mar 29, 2023

Weintraub Appointed to Illinois Supreme Court Commission on Elder Law

Mar 28, 2023

Comments are closed.

Latest News

Adolescent Sexual Health Program Receives Funding for Social Marketing Campaign

Mar 29, 2023

The Future of IgE-Mediated Allergy Research and Treatments

Mar 29, 2023

Weintraub Appointed to Illinois Supreme Court Commission on Elder Law

Mar 28, 2023

Investigating Protein’s Role in Hearing Loss

Mar 27, 2023

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230317_NM651
20230317_NM610
20230317_NM569
20230317_NM537
20230317_NM331
20230317_NM323
20230317_NM316
20230317_NM336
20230317_NM626
20230317_NM662
20230317_NM655
20230317_NM642

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.